Lalit Mohan Belwal

Lalit Mohan Belwal

Director Director DIN 02197444
DIN 02197444 First appointment Nov 2008 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Nov 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Lalit Mohan Belwal

Data last updated:

Lalit Mohan Belwal was a Director at Biozene Lab's Private Limited (2008–2019) and Director at Avlon Diagnostics Private Limited (from 2020). The companies operate in Pharma.

DIN 02197444
Primary Designation Director
Industry Pharma
First Appointment 14 Nov 2008
Oldest Company Age 6 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biozene Lab's Private Limited U24230MP2008PTC021320
Director14 Nov 20082008₹70.1 Lakh (FY 2025)Active
Avlon Diagnostics Private Limited U74999UP2020PTC134243
Director09 Sep 20202020Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Avlon Diagnostics Private Limited
Biozene Lab's Private Limited
Premium access

Shareholding and investment profile for Lalit Mohan Belwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lalit Mohan Belwal

Lalit Mohan Belwal was first appointed on 14 Nov 2008 as Director at Biozene Lab's Private Limited. The most recent appointment on record is 09 Sep 2020 at Avlon Diagnostics Private Limited.

Lalit Mohan Belwal held 2 earlier board appointments: Biozene Lab's Private Limited (Director, 14 Nov 2008 to 05 Apr 2019); Avlon Diagnostics Private Limited (Director, from 09 Sep 2020).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available